| Stage | CRTO | % of rev | OMC | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $428M | 100.00% | $6.4B | 100.00% | OMC ×15.01 |
| Gross profit | $222M | 51.92% | $1.4B | 21.16% | CRTO +30.8pp |
| Operating income | $15M | 3.51% | $992M | 15.44% | OMC +11.9pp |
| Pre-tax income | $15M | 3.58% | $888M | 13.82% | OMC +10.2pp |
| Net income | $12M | 2.75% | $675M | 10.50% | OMC +7.8pp |
| Stage | CRTO | OMC | Gap · A − B |
|---|---|---|---|
| Revenue | $428M100.00% | $6.4B100.00% | OMC ×15.01 |
| Gross profit | 51.92%$222M | 21.16%$1.4B | CRTO +30.8pp |
| Operating income | 3.51%$15M | 15.44%$992M | OMC +11.9pp |
| Pre-tax income | 3.58%$15M | 13.82%$888M | OMC +10.2pp |
| Net income |
| 2.75%$12M |
| 10.50%$675M |
| OMC +7.8pp |